A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...
Zacks Investment Research on MSN
Why is CRISPR Therapeutics (CRSP) up 3.3% since last earnings report?
It has been about a month since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 3.3% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.
The Food and Drug Administration this week granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...
Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback